Sanofi (NYSE: SNY) and Lexicon Pharma (Nasdaq: LXRX) announced that they have entered into a collaboration and license agreement for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Management Comments

Lexicon Pharma (LXRX) Tops Q3 EPS by 2cNovember 6, 2015 9:15 AM Sanofi (SNY) Will Outline Long-Term Roadmap; Sees Sales CAGR at 3% - 4% from 2015 -20November 6, 2015 6:25 AM Form 8-K LEXICON PHARMACEUTICALS, For: Nov 06November 6, 2015 6:09 AM Form 8-K LEXICON PHARMACEUTICALS, For: Nov 05November 6, 2015 6:07 AM Lexicon Pharmaceuticals Reports 3rd Quarter Financial Results And Discusses Collaboration With Sanofi For SotagliflozinNovember 6, 2015 6:00 AM